Unclaimed brand
Topmunnity Therapeutics Limited is advancing two pipeline products: an antibody-drug conjugate (ADC), TT-01 ADC and a chimeric antigen receptor T-Cell therapy CAR-108.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#FFBA1F
My Sin
255, 186, 31
42, 100, 56
0, 27, 88, 0
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#5F6360
Corduroy
95, 99, 96
135, 2, 38
4, 0, 3, 61
Topmunnity Therapeutics Limited is a dynamic oncology-focused drug development company that was established in 2019. Our primary goal is to address unmet medical needs by developing innovative therapies for cancer patients. At Topmunnity, we are dedicated to providing cutting-edge solutions that can make a real difference in the lives of those battling cancer.
As part of our mission, we are currently working on the development of a groundbreaking 2nd generation anti-PD-L1 drug. This drug holds immense promise in effectively targeting cancer cells and improving patient outcomes. Our team of experienced researchers and scientists is committed to pushing the boundaries of scientific innovation to bring this much-needed treatment to the market.
In addition to our focus on drug development, we also offer comprehensive research and software development services. This allows us to collaborate with other organizations and researchers, facilitating advancements in the field of oncology. At Topmunnity, we firmly believe that every patient has the right to be treated with the utmost care and compassion.
Join us in our mission to revolutionize cancer treatment and bring hope to those who need it most
